The U.S. Department of Veterans Affairs (VA) has awarded a $35,000 firm fixed-price delivery order contract to Natera Inc., a leading biotechnology company, for next-generation sequencing and peripheral blood circulating tumor DNA (ctDNA) testing services in support of cancer research. This contract is not designated as a set-aside. Natera has been a prime contractor for the VA, providing advanced genomic testing and analysis services, including tumor whole exome sequencing, minimal residual...
The U.S. Department of Veterans Affairs (VA) Headquarters awarded a new delivery order worth $499,447.00 to Natera Inc., a global leader in cell-free DNA testing. This order extends the period of performance for six months under an existing indefinite delivery contract between the VA and Natera valued at up to $6.72 million over two years. The contract is for Natera to provide minimal residual disease testing services, which analyze cell-free DNA biomarkers in patient blood samples to detect...
The Department of Veterans Affairs (VA) headquarters awarded an indefinite delivery contract to Natera Inc., doing business as Natera, for up to $6.72 million over two years. This contract covers the delivery of minimal residual disease testing services to detect remaining cancer cells in patients after initial treatment, guiding further treatment decisions. An initial delivery order worth $496,460 was issued to fund research and development activities related to this testing through Fiscal Year...
The Department of Veterans Affairs (VA) awarded a $129,475.00 contract to Color Health Inc. for hereditary cancer test kits, testing, and counseling services for the VA Puget Sound Healthcare System Research & Development. The contract is a firm-fixed-price purchase order with a one-year base period and one-year option. The original solicitation was issued as a commercial services contract under FAR Part 12 and 13, with a North American Industry Classification System (NAICS) code of 621511...
This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Personal Genome Diagnostics Inc., a for-profit company that provides molecular tissue testing services to federal agencies. The contract, valued at $147,900.00, requires the contractor to provide enhanced analysis of clinical and specimen-derived data on all cancer patients seen at VA network hospitals. The contractor shall furnish solutions for analyzing tissue samples obtained during clinical care...
The Department of Veterans Affairs (VA) awarded a firm fixed price delivery order contract to Foundation Medicine, Inc., a for-profit foreign-owned company, for $20,339,628.40 in genomic sequencing testing services. This contract is part of a larger indefinite delivery contract held by Foundation Medicine with VA Headquarters for genomic sequencing testing services to support VA programs, with a potential value over $111 million. The contract provides hematologic malignancies testing, next...
This is a firm-fixed price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Personalis, Inc., a genomic sequencing services provider. The contract, valued at $290,710.00, requires Personalis to provide enhanced analysis of clinical and specimen-derived data on all patients seen at VA network hospitals who have a cancer diagnosis. The contract incorporates the ACE CancerPlus test, a 181-gene cancer test, and is part of the VA's genomic...
The Department of Veterans Affairs awarded a $22.4 million delivery order contract to Foundation Medicine, Inc. for genomic sequencing testing services. The one-year firm fixed price contract will support VA's genomic medicine program by providing testing to help personalize cancer treatment for veterans. Performance will take place in Fredericksburg, Virginia. No subcontractors or set aside designations were identified. This delivery order was issued against an existing VA...
This is a firm-fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) to Personalis, Inc., a genomic sequencing services provider. The contract, valued at $99,440.00, requires Personalis to provide enhanced analysis of clinical and specimen-derived data for cancer patients seen at VA network hospitals. The contract incorporates the ACE CancerPLUS test, which is a 181-gene cancer test. This delivery order contract is part of a larger indefinite delivery vehicle...
This is a delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Foundation Medicine, Inc., a leading provider of genomic profiling and molecular analysis services. The contract, valued at $135,528.64, is for Next Generation Sequencing (NGS) testing services to support the VA's National Precision Oncology Program at the Richard L. Roudebush VA Medical Center. The contract is a Firm Fixed Price Delivery Order issued under a larger Indefinite Delivery Contract (IDC)...